Spectrum Pharmaceuticals, Inc., a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced the date and time for its third quarter 2010 corporate update and pipeline review conference call.
Spectrum Pharmaceuticals announces date and time for third quarter 2010 corporate update conference call